Need Help?

Dataset for the Pearl study

Biomarkers to identify patients without benefit from adding everolimus to endocrine treatment in metastatic breast cancer (MBC) are needed. We report the results of the Pearl trial conducted in five Belgian centers assessing 18F-FDG-PET/CT non-response (n=45) and ctDNA detection (n=46) after 14 days of exemestane-everolimus (EXE-EVE) to identify MBC patients who will not benefit. Metabolic non-response rate was 66.6%. Median PFS in non-responding patients (using as cut-off 25% for SUVmax decrease) was 3.1 months compared to 6.0 months in those showing response (HR: 0.77, 95% CI: 0.40-1.50, p=0.44). Difference was significant when using a “post-hoc” cut-off of 15% (PFS 2.2 months vs 6.4 months). ctDNA detection at D14 was associated with PFS: 2.1 months vs 5.0 months (HR-2.5, 95% CI: 1.3-5.0, p=0.012). Detection of ctDNA and/or the absence of 18F-FDG-PET/CT response after 14 days of EXE-EVE identifies patients with a low probability of benefiting from treatment. Independent validation is needed.

Request Access

Data policy for Pearl

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access dataset to which the User has requested access. The User agrees to be bound by these terms and conditions. Definitions: Data means all and any human genetic data obtained from this study/dataset. User means a researcher who has previously completed the Data Access Agreement. User Institution means the organisation at which the User is employed, affiliated or enrolled. Publications means, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Terms and Conditions: In signing this Agreement: You agree to use the Data only for research purposes. You agree to preserve, at all times, the confidentiality of information and Data. You agree not to transfer or disclose the Data, in whole or part, or any identifiable material derived from the Data, to others, except as necessary for data/safety monitoring or programme management. Should You wish to share the Data with a collaborator outwith the same Institution, the third party must make a separate application for access to the Data. You agree to use the data for the approved purpose and project described in your application; use of the data for a new purpose or project will require a new application and approval. You agree to acknowledge in any work based in whole or part on the Data, the published paper from which the Data derives. You understand and acknowledge that the Data is protected by copyright and other intellectual property rights, and that duplication, except as reasonably required to carry out Your research with the Data, or sale of all or part of the Data on any media is not permitted. You recognise that nothing in this agreement shall operate to transfer to the User Institution any intellectual property rights relating to the Data. You accept that this agreement will terminate immediately upon any breach of this agreement by You and You will be required to destroy any Data held.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS00001005523 Cancer Genomics

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Quality Report
Located in
EGAF00005420431 bam 1.6 GB Report
EGAF00005420479 bam 3.7 GB Report
EGAF00005420480 bam 5.0 GB Report
EGAF00005420481 bam 4.1 GB Report
EGAF00005420482 bam 2.5 GB Report
EGAF00005420483 bam 4.7 GB Report
EGAF00005420484 bam 1.5 GB Report
EGAF00005420485 bam 3.5 GB Report
EGAF00005420486 bam 4.2 GB Report
EGAF00005420487 bam 3.0 GB Report
EGAF00005420488 bam 1.5 GB Report
EGAF00005420489 bam 1.9 GB Report
EGAF00005420490 bam 3.9 GB Report
EGAF00005420491 bam 2.5 GB Report
EGAF00005420492 bam 858.2 MB Report
EGAF00005420493 bam 2.8 GB Report
EGAF00005420494 bam 1.7 GB Report
EGAF00005420495 bam 940.2 MB Report
EGAF00005420496 bam 2.7 GB Report
EGAF00005420497 bam 3.8 GB Report
EGAF00005420498 bam 3.3 GB Report
EGAF00005420499 bam 1.9 GB Report
EGAF00005420500 bam 1.2 GB Report
EGAF00005420501 bam 3.0 GB Report
EGAF00005420502 bam 2.7 GB Report
EGAF00005420503 bam 4.8 GB Report
EGAF00005420504 bam 4.7 GB Report
EGAF00005420505 bam 2.2 GB Report
EGAF00005420506 bam 3.1 GB Report
EGAF00005420507 bam 2.3 GB Report
EGAF00005420508 bam 2.5 GB Report
EGAF00005420509 bam 2.3 GB Report
EGAF00005420510 bam 2.7 GB Report
EGAF00005420511 bam 3.1 GB Report
EGAF00005420512 bam 1.9 GB Report
EGAF00005420513 bam 1.5 GB Report
EGAF00005420514 bam 3.5 GB Report
EGAF00005420515 bam 3.6 GB Report
EGAF00005420516 bam 3.8 GB Report
EGAF00005420517 bam 3.3 GB Report
EGAF00005420518 bam 4.0 GB Report
EGAF00005420519 bam 2.7 GB Report
EGAF00005420520 bam 2.4 GB Report
EGAF00005420521 bam 2.5 GB Report
EGAF00005420522 bam 1.9 GB Report
EGAF00005420523 bam 2.8 GB Report
EGAF00005420524 bam 1.0 GB Report
EGAF00005420525 bam 3.8 GB Report
EGAF00005420526 bam 4.6 GB Report
EGAF00005420527 bam 1.6 GB Report
EGAF00005420528 bam 3.2 GB Report
EGAF00005420529 bam 938.9 MB Report
EGAF00005420530 bam 487.0 MB Report
EGAF00005420531 bam 2.3 GB Report
EGAF00005420532 bam 2.8 GB Report
EGAF00005420533 bam 3.0 GB Report
EGAF00005420534 bam 2.9 GB Report
EGAF00005420535 bam 3.1 GB Report
EGAF00005420536 bam 3.9 GB Report
EGAF00005420537 bam 3.4 GB Report
EGAF00005420538 bam 4.4 GB Report
EGAF00005420539 bam 2.5 GB Report
EGAF00005420540 bam 2.9 GB Report
EGAF00005420541 bam 1.5 GB Report
EGAF00005420542 bam 2.1 GB Report
EGAF00005420543 bam 2.1 GB Report
EGAF00005420544 bam 2.0 GB Report
EGAF00005420545 bam 1.6 GB Report
EGAF00005420546 bam 3.3 GB Report
EGAF00005420547 bam 2.4 GB Report
EGAF00005420548 bam 2.0 GB Report
EGAF00005420549 bam 1.8 GB Report
EGAF00005420550 bam 3.0 GB Report
EGAF00005420551 bam 2.8 GB Report
EGAF00005420552 bam 2.7 GB Report
EGAF00005420553 bam 2.4 GB Report
EGAF00005420554 bam 3.7 GB Report
EGAF00005420555 bam 5.8 GB Report
EGAF00005420556 bam 2.3 GB Report
EGAF00005420557 bam 2.6 GB Report
EGAF00005420558 bam 3.4 GB Report
EGAF00005420559 bam 1.9 GB Report
EGAF00005420560 bam 1.9 GB Report
EGAF00005420561 bam 2.2 GB Report
EGAF00005420562 bam 3.2 GB Report
EGAF00005420563 bam 1.2 GB Report
EGAF00005420564 bam 1.9 GB Report
EGAF00005420565 bam 3.2 GB Report
EGAF00005420566 bam 2.8 GB Report
EGAF00005420567 bam 2.9 GB Report
EGAF00005420568 bam 2.4 GB Report
EGAF00005420569 bam 3.8 GB Report
EGAF00005420570 bam 2.2 GB Report
EGAF00005420571 bam 2.1 GB Report
EGAF00005420572 bam 4.4 GB Report
EGAF00005420573 bam 2.6 GB Report
EGAF00005420574 bam 3.9 GB Report
EGAF00005420575 bam 2.3 GB Report
EGAF00005420576 bam 1.6 GB Report
EGAF00005420577 bam 3.5 GB Report
EGAF00005420578 bam 1.8 GB Report
EGAF00005420579 bam 2.5 GB Report
EGAF00005420580 bam 2.8 GB Report
EGAF00005420581 bam 3.2 GB Report
EGAF00005420582 bam 2.4 GB Report
EGAF00005420583 bam 2.6 GB Report
EGAF00005420584 bam 1.9 GB Report
EGAF00005420585 bam 3.7 GB Report
EGAF00005420586 bam 2.8 GB Report
EGAF00005420587 bam 3.2 GB Report
EGAF00005420588 bam 3.3 GB Report
EGAF00005420589 bam 3.0 GB Report
EGAF00005420590 bam 2.0 GB Report
EGAF00005420591 bam 2.5 GB Report
EGAF00005420592 bam 2.6 GB Report
EGAF00005420593 bam 3.5 GB Report
EGAF00005420594 bam 3.7 GB Report
EGAF00005420595 bam 3.8 GB Report
EGAF00005420596 bam 1.7 GB Report
EGAF00005420597 bam 2.5 GB Report
EGAF00005420598 bam 2.9 GB Report
EGAF00005420599 bam 2.1 GB Report
EGAF00005420600 bam 3.0 GB Report
EGAF00005420601 bam 3.1 GB Report
EGAF00005420602 bam 3.3 GB Report
EGAF00005420603 bam 1.3 GB Report
126 Files (344.7 GB)